158 related articles for article (PubMed ID: 2944820)
1. Human T cell subsets differ in their ability to migrate in vitro and to produce T cell migration inhibitory factor.
Kowalczyk D; Pryjma J; Zembala M
Immunol Lett; 1986 Aug; 13(1-2):33-8. PubMed ID: 2944820
[TBL] [Abstract][Full Text] [Related]
2. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.
Berman JS; Cruikshank WW; Center DM; Theodore AC; Beer DJ
Cell Immunol; 1985 Oct; 95(1):105-12. PubMed ID: 3161625
[TBL] [Abstract][Full Text] [Related]
3. Monocyte regulation of lymphokine production in cancer patients.
Kowalczyk D; Ruggiero I; Zembala M
J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
[TBL] [Abstract][Full Text] [Related]
5. Patients with abnormal proportions of T-lymphocyte subsets have reduced in vitro cellular immunity.
Chudwin DS; Cowan MJ; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1983 Jan; 26(1):126-36. PubMed ID: 6223739
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population.
Thomas Y; Rogozinski L; Rabbani L; Chess A; Goldstein G; Chess L
J Mol Cell Immunol; 1984; 1(2):103-13. PubMed ID: 6152892
[TBL] [Abstract][Full Text] [Related]
7. The cellular basis for differential lymphokine responses to mitogen stimulation.
MacSween JM; Rajaraman K; Rajaraman R
Cell Immunol; 1986 Aug; 101(1):82-92. PubMed ID: 2943417
[TBL] [Abstract][Full Text] [Related]
8. Effects of indomethacin on lymphocyte proliferation, suppressor cell function, and leukocyte migration inhibitory factor (lmif) production.
Soppi E; Eskola J; Ruuskanen O
Immunopharmacology; 1982 Jun; 4(3):235-42. PubMed ID: 6213582
[TBL] [Abstract][Full Text] [Related]
9. Active T rosettes, human autologous T rosettes, OKT8 and OKT4 cells, con A-induced suppressive activity, and autoantibodies: clinical correlations.
Schandené L; Vanden Steen F; Romasco F; Wybran J
Clin Immunol Immunopathol; 1983 Aug; 28(2):147-54. PubMed ID: 6223764
[TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitive suppressor T cells for LIF production in mixed lymphocyte reactions.
Sandru G; Veraguth P; de Weck A
Immunobiology; 1984 May; 166(3):263-74. PubMed ID: 6234226
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of peripheral blood lymphocytes to growth inhibition by hydrocortisone is not determined by their OKT4:OKT8 ratio.
Roberts C; Potts RC; Brown RA; Gibbs JH; Browning MC; Beck JS
Immunol Lett; 1983 Apr; 6(4):227-30. PubMed ID: 6224743
[TBL] [Abstract][Full Text] [Related]
13. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
Thomas Y; Rogozinski L; Rothman P; Rabbani LE; Andrews S; Irigoyen OH; Chess L
J Clin Immunol; 1982 Jul; 2(3 Suppl):8S-14S. PubMed ID: 6215426
[TBL] [Abstract][Full Text] [Related]
14. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
15. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
[TBL] [Abstract][Full Text] [Related]
16. Effector activity of OKT4+ and OKT8+ T-cell subsets in lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells.
Perl A; Gonzalez-Cabello R; Láng I; Gergely P
Cell Immunol; 1984 Mar; 84(1):185-93. PubMed ID: 6230158
[TBL] [Abstract][Full Text] [Related]
17. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
Kobayashi Y; Asada M; Higuchi M; Osawa T
J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
[TBL] [Abstract][Full Text] [Related]
18. Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators.
Masucci G; Szigeti R; Stevens D; Masucci MG; Klein E; Petersen J; Bendtzen K; Klein G
Cell Immunol; 1984 May; 85(2):511-8. PubMed ID: 6325026
[TBL] [Abstract][Full Text] [Related]
19. Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.
Varesio L; Holden HT
Cell Immunol; 1980 Nov; 56(1):16-28. PubMed ID: 6253087
[No Abstract] [Full Text] [Related]
20. Stimulation and inhibition of human granulopoiesis in vitro by normal and malignant T4- or T8-lymphocyte subpopulations.
Bonnefoix T; Sotto JJ; Pegourie B; Piccinni MP
Exp Hematol; 1987 Jul; 15(6):645-51. PubMed ID: 2954841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
